The ability to turn human cells into anything we want sounds like the stuff of science fiction. But one Cambridge biotech says it's cracked the code
Through wholly-owned subsidiaries such as Lyramid, Kinera and Advangen, the company develops and markets innovative novel therapies as well as diagnostic tests for inflammatory...
The company said revenue came in at DKK 6.6 million (US$980,000), compared to DKK 5.4 million (US$800,000) in the prior-year quarter
In the study, humanized immunodeficient mice were fed a high fat diet, and treated with leronlimab which inhibited fatty liver development
This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange
Glycotest Inc has received US$3mln, which help fund the commercialisation of its liver cancer diagnostic